Suchergebnisse - "Hernán, Miguel A"

PubPharm (13)

1

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain : a nationwide cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Monge, S. | Rojas-Benedicto, A. | Olmedo, C. | +53

CommentIn: Lancet Infect Dis. 2022 Sep;22(9):1257-1258. - PMID 35658999

2

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age

enthalten in: The New England journal of medicine | 2022

von Cohen-Stavi, C. | Magen, O. | Barda, N. | +11

3

Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England : cohort study using OpenSAFELY

enthalten in: BMJ (Clinical research ed.) | 2022

von Hulme, W. | Williamson, E. | Green, A. | +39

4

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose : OpenSAFELY cohort study using linked electronic health records

enthalten in: BMJ (Clinical research ed.) | 2022

von Horne, E. | Hulme, W. | Keogh, R. | +26

5

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply

enthalten in: The New England journal of medicine | 2022

von Waxman, J. | Magen, O. | Hernán, M.

CommentOn: N Engl J Med. 2022 Jul 14;387(2):191. - PMID 35767517

6

Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans

enthalten in: JAMA internal medicine | 2022

von Dickerman, B. | Madenci, A. | Gerlovin, H. | +9

7

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

enthalten in: The New England journal of medicine | 2022

von Magen, O. | Waxman, J. | Makov-Assif, M. | +7

CommentIn: N Engl J Med. 2022 Apr 28;386(17):1661-1662. - PMID 35417633

8

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

enthalten in: The New England journal of medicine | 2022

von Dickerman, B. | Gerlovin, H. | Madenci, A. | +8

CommentIn: N Engl J Med. 2022 Jan 13;386(2):183-185. - PMID 34942068

9

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel : an observational study

enthalten in: Lancet (London, England) | 2021

von Barda, N. | Dagan, N. | Cohen, C. | +5

CommentIn: Lancet. 2021 Dec 4;398(10316):2055-2057. - PMID 34756185

10

Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents

enthalten in: The New England journal of medicine | 2021

von Reis, B. | Barda, N. | Leshchinsky, M. | +5